Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it will
voluntarily withdraw the contingent value rights (CVRs) it issued under
a Contingent Value Rights Agreement dated October 24, 2013 (CVR
Agreement) from listing on the NASDAQ Global Select Market on February
2, 2015, contemporaneously with their redemption.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.